The scarcity of IL-17 continues to be reported to mitigate hypertensive cardiac hypertrophy also, dilated cardiomyopathy and myocardial infarction 48, 83, 84 (Table ?(Desk33). The
The scarcity of IL-17 continues to be reported to mitigate hypertensive cardiac hypertrophy also, dilated cardiomyopathy and myocardial infarction 48, 83, 84 (Table ?(Desk33). The